The number of pipeline Nephrology and Urology products in 2021 saw a 75% rise globally when compared to Nephrology and Urology pipeline products in 2020, according to GlobalData’s pipeline products database. This compares to a 15% rise for all pipeline medical devices in 2021 compared to 2020.
The global Nephrology and Urology Devices market was worth $9.59bn in 2020 and is expected to reach $10.26bn by 2025, according to GlobalData’s analysis.
Nephrology and Urology Devices pipeline products by categories: Renal Dialysis Equipment has the most devices
Looking at the device categories of pipeline products, Renal Dialysis Equipment accounted for the largest proportion (29.17%) in 2021, followed by Incontinence Devices (27.08%) and Urinary Tract Stents (4.17%).
Of the global medical devices market value, the Nephrology and Urology Devices market held a 2% share worth $9bn in 2021 and is expected to reach $10.26bn by 2025.
Nephrology and Urology Devices development activity: Advanced stage of development leads
Devices at an advanced stage of development (in clinical trials, in the approval process, already approved in Europe or the rest of the world) accounted for 45.65% of medical devices in 2021, compared with 37.93% in 2020. The number of devices at the In Approval stage inclined by 100% in 2021, when compared with 2020.
The In Approval stage is considered to be the period where the manufacturer is waiting for final approval from regulators, following completion of the required development steps.
A decrease in products awaiting approval would indicate less new products entering the market in the coming months, while an increase indicates more devices entering the market, posing a market share threat to existing marketed devices.
North America tops pipeline Nephrology and Urology Devices products activity
Comparing the number of pipeline Nephrology and Urology Devices products activity in different regions of the globe, North America held the top position (59%) during 2021, followed by Europe (27%), and Asia-Pacific (8%).
On a country level, the US had the most pipeline Nephrology and Urology Devices during the year, representing the largest share (65%) of Nephrology and Urology pipeline products. In second place was United Kingdom (6%), followed by Israel (6%).
New pipeline Nephrology and Urology medical devices: Expected to be approved by 2025
According to GlobalData, approximately 43% of pipeline Nephrology and Urology Devices in 2021 were expected to receive regulatory approval by the end of 2025. The leading categories for devices expected to receive regulatory approval by the end of 2025 was Urinary Catheters, at 6% of devices. Differences in regulatory approval timelines reflect the stage of development for a device, the device complexity or risk categorization (or device class) or if there are changes in regulatory oversight.
Cook Medical Inc tops Nephrology and Urology Devices development in 2021
According to GlobalData, top ten medical device companies accounted for 29.17% of pipeline Nephrology and Urology Devices activity during 2021. The leading company for developing Nephrology and Urology Devices was Cook Medical Inc with 6.25%, followed by Boston Scientific Corp at 4.17%.
Companies launching new medical devices are more likely to disrupt existing market share or are better able to defend existing share.
Company-developed pipeline products lead Nephrology and Urology Devices in development
Looking at the share of activity in terms of Nephrology and Urology pipeline products developers, company-developed pipeline products accounted for a 90% share of the Nephrology and Urology medical devices market, while institute-developed pipeline products held the remaining share.
The monthly average for 2021 saw company-developed Nephrology and Urology pipeline products account for 90% of pipeline products and institute-developed pipeline products account for 10%.
The medical devices pipeline data used in this article were extracted from Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database covers all medical devices which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. Pipeline products are covered from various authenticated sources like company websites, SEC filings, conference presentations, analyst presentations, news releases, grants etc. The information is collected by following systematic research techniques and proprietary methodology.